secwatch.observer — SEC 8-K summary
======================================

Issuer:     Morphic Holding, Inc. (—)
CIK:        0001679363
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001193125-24-202123
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eli Lilly completes acquisition of Morphic Holding for $57.00 per share; shares delisted
--------------------------------------------------------------------------------

- Tender offer expired with 46,731,511 shares (92.8%) tendered, accepting all at $57.00 per share cash.
- Merger completed under DGCL 251(h); all remaining shares converted to $57.00 cash, same as offer price.
- All outstanding stock options and restricted stock units vested and cashed out at $57.00 per share, net of exercise price.
- Morphic's board resigned; replaced by Gordon Brooks, Michael Thompson, and Christopher Anderson from Lilly.
- Morphic shares suspended from Nasdaq; deregistration and termination of equity plans and Sales Agreement effective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1679363/000119312524202123/0001193125-24-202123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1679363/000119312524202123/d877674d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-202123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer